Month: May 2013

By Terry Baynes (Reuters) – The Food and Drug Administration on Wednesday appealed a court order directing the agency to make "morning-after" emergency contraception pills available without a prescription to all girls of reproductive age. Lawyers with the Justice Department filed the appeal with the 2nd U.S. Circuit Court of Appeals in New York, according to court documents. The appeal is the latest foray in the years-long legal battle over the pill known as "Plan B," a drug that has also sparked political and religious clashes. …

Chicken nuggets are out and tofu is in at one New York City school.        

WASHINGTON (AP) — The Justice Department is appealing a judge's decision lifting all age limits on the Plan B morning-after birth control pill and a cheaper generic.

WASHINGTON (Reuters) – Employer-sponsored healthcare plans cannot include most “wellness programs” as part of minimum coverage requirements, dealing a setback to many businesses, according to new federal rules for U.S. President Barack Obama’s healthcare overhaul starting next year. The Internal Revenue Service released on Tuesday proposed rules for Obama’s 2010 Affordable Care Act that handed a victory to labor unions and consumer groups, tax lawyers said on Wednesday. …

ABC News’ Lisa Stark and Enjoli Francis report: Pop an Ambien – or its generic version, zolpidem – and you’re supposed to get a good night’s rest. But according to a new study released today, a growing number of users are ending up in the…        

ABC News’ Lisa Stark and Enjoli Francis report: Pop an Ambien – or its generic version, zolpidem – and you’re supposed to get a good night’s rest. But according to a new study released today, a growing number of users are ending up in the…        

By Esha Dey and Ransdell Pierson (Reuters) – Allergan Inc said approval of its Darpin eye drug could be delayed up to two years, providing a new boost to Regeneron Pharmaceuticals Inc whose successful treatment, Eylea, stands to gain from a lack of new competition. Shares of Allergan, which makes wrinkle treatment Botox, fell 13.1 percent after the company said mid-stage trial results of Darpin did not warrant an immediate move into far larger late-stage trials. Regeneron shares closed up 10.3 percent. …

Energy drinks and soda? Yawn. Now it’s all about inserting caffeine into other foods, from potato chips to mints. What’s behind our need for more caffeine?